ZyVersa Therapeutics Inc. (ZVSA)

AI Score

Unlock

0.72

0.01 (1.69%)

At close: Apr 24, 2025, 3:59 PM

0.72

0.06%

After-hours: Apr 24, 2025, 07:47 PM EDT

ZyVersa Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	1.53M	122.92K	119.49K	2.03M	3.14M	1.58M	228.69K	1.28M	5.9M	602.75K	31.46K	347.93K	328.58K	686.5K	702.48K	-174.67
Short-Term Investments	1.53B	122.8M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	349.34
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	78.91M	n/a	n/a	75.75M	n/a	n/a	n/a
Other Long-Term Assets	18.86B	385.61K	178.48K	98.48K	98.48K	n/a	n/a	46.66K	46.66K	-78.79M	166.66K	226.66K	-75.46M	402.41K	320.61K	227.84K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	184.87M	267.49M	521.91K	866.48K	215.46K	426.52K	886.91K	1.56M	460.35K	1.6M	1.72M	903.56K	483.2K	n/a	n/a	n/a
Total Current Assets	1.72B	390.42M	641.39K	2.9M	3.35M	2.01M	1.12M	2.83M	6.36M	2.2M	1.75M	1.25M	811.78K	686.5K	702.48K	174.67
Property-Plant & Equipment	n/a	n/a	1.73K	4.33K	14.77K	40.61K	66.03K	91.06K	115.7K	19.93K	22.53K	25.13K	27.73K	n/a	n/a	n/a
Goodwill & Intangibles	18.65M	18.65M	18.65M	18.65M	18.65M	30.81M	30.81M	111.98M	111.98M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	18.88B	19.03M	18.83M	18.75M	18.76M	30.85M	30.87M	112.12M	112.14M	146.59K	189.19K	251.79K	314.39K	402.41K	320.61K	227.84K
Total Assets	20.6B	19.42M	19.47M	21.65M	22.11M	32.85M	31.99M	114.95M	118.51M	2.35M	1.94M	1.5M	1.13M	1.09M	1.02M	228.5K
Account Payables	9.34M	9.28M	8.32M	8.13M	8.43M	8.9M	8.14M	6.38M	6.03M	6.5M	4.2M	3.23M	2M	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	2.27M	1.76M	n/a	n/a	12.08K	13.77K	15.47K	765.68K	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	34.35K	59.63K	84.51K	108.76K	3.96M	9.19M	9.18M	9.15M	719.08K	719.08K	n/a
Other Current Liabilities	1.89M	7.26K	29.23K	59.23K	1.09M	538.79K	564.65K	7.25M	1.36M	2.79M	3.22M	2.81M	1.71M	349.83K	283.84K	228.94K
Total Current Liabilities	11.23M	11.54M	9.99M	9.58M	10.19M	11.71M	10.48M	8.58M	8.19M	14.15M	17.16M	15.42M	13.63M	1.07M	1M	228.94K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	850.81M	853.77M	-1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	719.08K	719.08K	n/a
Total Long-Term Liabilities	851.66M	854.62M	854.62K	844.91K	844.91K	1.44M	1.44M	9.28M	10.32M	10.47M	13.39M	3.38M	11.15M	719.08K	719.08K	n/a
Total Liabilities	12.08B	12.4M	10.85M	10.43M	11.04M	13.15M	11.93M	17.86M	18.51M	14.15M	17.16M	15.42M	13.63M	1.07M	1M	228.94K
Total Debt	n/a	n/a	n/a	n/a	8.66K	34.35K	59.63K	84.51K	108.76K	3.96M	9.19M	9.18M	9.15M	719.08K	719.08K	n/a
Common Stock	251.00	107.00	83.00	83.00	405.00	4.35K	2.37K	922.00	902.00	242.00	242.00	242.00	242.00	216.00	216.00	216.00
Retained Earnings	-112.63B	-111.21M	-108.81M	-106.05M	-103.22M	-89.88M	-86.98M	-8.47M	-4.92M	-62.34M	-58.65M	-56.65M	-52.9M	-2.07K	-1.9K	-1.11K
Comprehensive Income	n/a	n/a	n/a	-1K	-405	n/a	-104.15B	n/a	n/a	n/a	n/a	-242	-75.75M	n/a	n/a	n/a
Shareholders Equity	8.52B	7.03M	8.62M	11.22M	11.07M	19.7M	20.06M	97.1M	99.99M	-11.8M	-15.22M	-13.91M	-12.5M	19.99K	20.17K	-8.89K
Total Investments	1.53B	122.8M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	78.91M	n/a	n/a	75.75M	n/a	n/a	349.34